Lanean...
The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
Gorde:
| Argitaratua izan da: | Clin Case Rep |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7495745/ https://ncbi.nlm.nih.gov/pubmed/32983485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2967 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|